If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
&lt;br /&gt; ASPERGILLOSIS&lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; Adapted from:&lt;br /&gt; IDSA Guidelines&lt;br /&gt; Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis:&lt;br /&gt; clinical practice guidelines of the Infectious Diseases Society of&lt;br /&gt; America. Clin Infect Dis. 2008;46:327-360.&lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; Key Points&lt;br /&gt; &lt;br /&gt; Diagnosis&lt;br /&gt; &lt;br /&gt; Selecting a Treatment Regimen&lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; &lt;br /&gt; www.GuidelineCentral.com&lt;br /&gt; Key Points&lt;br /&gt; &Icirc;Aspergillus spp infection is a major cause of morbidity and mortality in&lt;br /&gt; immunocompromised patients&lt;br /&gt; &Icirc;Invasive aspergillosis (IA) involves<a title="Aspergillosis_viewer110809.pdf page 1" href="http://viewer.zmags.com/publication/4e48a1a8?page=1">ASPERGILLOSISAdapted from:IDSA GuidelinesWa</a> ASPERGILLOSISAdapted from:IDSA GuidelinesWa<a title="Aspergillosis_viewer110809.pdf page 2" href="http://viewer.zmags.com/publication/4e48a1a8?page=2">Key Points&Icirc;Aspergillus spp infection is a major </a> Key Points&Icirc;Aspergillus spp infection is a major <a title="Aspergillosis_viewer110809.pdf page 3" href="http://viewer.zmags.com/publication/4e48a1a8?page=3">Empirical or Pre-Emptive Therapy in Neutropenic P</a> Empirical or Pre-Emptive Therapy in Neutropenic P<a title="Aspergillosis_viewer110809.pdf page 4" href="http://viewer.zmags.com/publication/4e48a1a8?page=4">DiagnosisDiagnosis of Invasive AspergillosisDet</a> DiagnosisDiagnosis of Invasive AspergillosisDet<a title="Aspergillosis_viewer110809.pdf page 5" href="http://viewer.zmags.com/publication/4e48a1a8?page=5">Selecting a Treatment RegimenTable 3. Relative I</a> Selecting a Treatment RegimenTable 3. Relative I<a title="Aspergillosis_viewer110809.pdf page 6" href="http://viewer.zmags.com/publication/4e48a1a8?page=6">Selecting a Treatment Regimen </a> Selecting a Treatment Regimen <a title="Aspergillosis_viewer110809.pdf page 7" href="http://viewer.zmags.com/publication/4e48a1a8?page=7"> EarlyTreatmentandPreventionofIAinHigh-</a> EarlyTreatmentandPreventionofIAinHigh-<a title="Aspergillosis_viewer110809.pdf page 8" href="http://viewer.zmags.com/publication/4e48a1a8?page=8">Selecting a Treatment RegimenTable 1. Antifungal</a> Selecting a Treatment RegimenTable 1. Antifungal<a title="Aspergillosis_viewer110809.pdf page 9" href="http://viewer.zmags.com/publication/4e48a1a8?page=9">CommentsCausesacuteinfusion-relatedreactions&mdash;f</a> CommentsCausesacuteinfusion-relatedreactions&mdash;f<a title="Aspergillosis_viewer110809.pdf page 10" href="http://viewer.zmags.com/publication/4e48a1a8?page=10">Selecting a Treatment RegimenTable 2. Recommen</a> Selecting a Treatment RegimenTable 2. Recommen<a title="Aspergillosis_viewer110809.pdf page 11" href="http://viewer.zmags.com/publication/4e48a1a8?page=11">yaAlternativeb </a> yaAlternativeb <a title="Aspergillosis_viewer110809.pdf page 12" href="http://viewer.zmags.com/publication/4e48a1a8?page=12">To view more eGuidelineViewers please visit:ww</a> To view more eGuidelineViewers please visit:ww